Danaher | Des Atouts



Assets Changement Date
Abbott USD 81.41B 7.06B 2024-12
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.21B 151.37M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
ESCO Technologies USD 1.8B 43.56M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
Fortive USD 17.02B 437.5M 2024-12
Henry Schein USD 10.22B 387M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Illumina USD 6.3B 289M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Keysight Technologies USD 9.39B 118M 2025-01
Laboratory Of America USD 18.38B 233.5M 2024-12
Medtronic USD 89.97B 69M 2025-01
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Patterson Companies USD 2.83B 13.02M 2025-01
Quest Diagnostics USD 16.15B 58M 2024-12
Quidel USD 6.42B 377.5M 2024-12
Repligen USD 2.83B 31.28M 2024-09
Revvity USD 12.39B 377.26M 2024-12
Roper Industries USD 31.33B 218M 2024-12
Stryker USD 42.97B 862M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Waters USD 4.55B 42.18M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Danaher Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.